Literature DB >> 7194443

Safety of anticonvulsants in hepatic porphyrias.

N C Reynolds, R M Miska.   

Abstract

Because acute attacks of porphyria may be precipitated by anticonvulsants, a therapeutic dilemma arises when seizures complicate hepatic porphyria. The list of unsafe agents includes barbiturates, primidone, phenytoin, mephenytoin, ethotoin, ethosuximide, methsuximide, phensuximide, and trimethadione. Agents are considered unsafe if they induce experimental porphyria in animals, and short trials in patients are unreliable for screening. Using drug incubation in chick-embryo hepatocyte culture, we found that porphyrin was increased by carbamazepine, clonazepam, and valproate. These agents should probably be avoided or used with caution in porphyric patients. Alternative approaches to acute porphyric attacks with seizures are discussed.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7194443     DOI: 10.1212/wnl.31.4.480

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  4 in total

1.  Acute intermittent porphyria presenting as epilepsy.

Authors:  A C Scane; J P Wight; R B Godwin-Austen
Journal:  Br Med J (Clin Res Ed)       Date:  1986-04-05

Review 2.  The little imitator--porphyria: a neuropsychiatric disorder.

Authors:  H L Crimlisk
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-04       Impact factor: 10.154

3.  Levetiracetam in idiopathic generalised epilepsy and porphyria cutanea tarda.

Authors:  Leonilda Bilo; Roberta Meo; Maria Fulvia de Leva
Journal:  Clin Drug Investig       Date:  2006       Impact factor: 2.859

Review 4.  Pharmacokinetic changes of psychotropic drugs in patients with liver disease: implications for dose adaptation.

Authors:  Chantal Schlatter; Sabin S Egger; Lydia Tchambaz; Stephan Krähenbühl
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.